Feilong Qi

14 papers and 381 indexed citations i.

About

Feilong Qi is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Feilong Qi has authored 14 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Feilong Qi’s work include Inflammatory Biomarkers in Disease Prognosis (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Feilong Qi is often cited by papers focused on Inflammatory Biomarkers in Disease Prognosis (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Feilong Qi collaborates with scholars based in China, Singapore and Australia. Feilong Qi's co-authors include Guangjun Nie, Zefang Lu, Bozhao Li, Suping Li, Tianjiao Chu, Jingyan Wei, Mengxue Dong, Li Ye, Kudelaidi Kuerban and Yinlong Zhang and has published in prestigious journals such as Nano Letters, Nature reviews. Cancer and ACS Applied Materials & Interfaces.

In The Last Decade

Co-authorship network of co-authors of Feilong Qi i

Fields of papers citing papers by Feilong Qi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feilong Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feilong Qi. The network helps show where Feilong Qi may publish in the future.

Countries citing papers authored by Feilong Qi

Since Specialization
Citations

This map shows the geographic impact of Feilong Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feilong Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feilong Qi more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2025